Private & ConfidentialArtiva Biotherapeutics, Inc. • June 6th, 2022 • Biological products, (no disgnostic substances)
On behalf of Artiva Biotherapeutics, Inc. (the “Company”), I am pleased to offer you employment under the terms set forth in this offer letter agreement (this “Agreement”). These employment terms are contingent upon reference check and Board approval, and will be effective as of your start date, which will be on or before June 6, 2022 (the “Start Date”). This offer will become void if not accepted by May 24, 2022.
FIRST AMENDMENT TO LICENSE AGREEMENTLicense Agreement • June 6th, 2022 • Artiva Biotherapeutics, Inc. • Biological products, (no disgnostic substances)
THIS FIRST AMENDMENT TO LICENSE AGREEMENT (this “First Amendment”) is made as of May 9, 2022, by and between ARE-SD REGION NO. 37, LLC, a Delaware limited liability company (“Licensor”), and ARTIVA BIOTHERAPEUTICS, INC., a Delaware corporation (“Licensee”).
